1. Home
  2. PSNL vs GLAD Comparison

PSNL vs GLAD Comparison

Compare PSNL & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • GLAD
  • Stock Information
  • Founded
  • PSNL 2011
  • GLAD 2001
  • Country
  • PSNL United States
  • GLAD United States
  • Employees
  • PSNL N/A
  • GLAD N/A
  • Industry
  • PSNL Medical Specialities
  • GLAD Finance/Investors Services
  • Sector
  • PSNL Health Care
  • GLAD Finance
  • Exchange
  • PSNL Nasdaq
  • GLAD Nasdaq
  • Market Cap
  • PSNL 518.8M
  • GLAD 612.5M
  • IPO Year
  • PSNL 2019
  • GLAD N/A
  • Fundamental
  • Price
  • PSNL $5.82
  • GLAD $23.57
  • Analyst Decision
  • PSNL Strong Buy
  • GLAD Hold
  • Analyst Count
  • PSNL 4
  • GLAD 3
  • Target Price
  • PSNL $8.13
  • GLAD $24.83
  • AVG Volume (30 Days)
  • PSNL 824.9K
  • GLAD 207.4K
  • Earning Date
  • PSNL 11-05-2025
  • GLAD 11-12-2025
  • Dividend Yield
  • PSNL N/A
  • GLAD 8.40%
  • EPS Growth
  • PSNL N/A
  • GLAD N/A
  • EPS
  • PSNL N/A
  • GLAD 3.38
  • Revenue
  • PSNL $80,317,000.00
  • GLAD $88,900,000.00
  • Revenue This Year
  • PSNL N/A
  • GLAD N/A
  • Revenue Next Year
  • PSNL $29.83
  • GLAD $13.91
  • P/E Ratio
  • PSNL N/A
  • GLAD $6.97
  • Revenue Growth
  • PSNL 0.36
  • GLAD N/A
  • 52 Week Low
  • PSNL $2.83
  • GLAD $21.96
  • 52 Week High
  • PSNL $7.79
  • GLAD $30.43
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 60.46
  • GLAD 30.47
  • Support Level
  • PSNL $5.48
  • GLAD $22.84
  • Resistance Level
  • PSNL $6.26
  • GLAD $26.29
  • Average True Range (ATR)
  • PSNL 0.33
  • GLAD 0.56
  • MACD
  • PSNL 0.11
  • GLAD -0.17
  • Stochastic Oscillator
  • PSNL 72.86
  • GLAD 19.41

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

Share on Social Networks: